|

RE104 for Injection Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • Reunion Neuroscience Inc1

Indications

  • Adjustment Disorder1
  • Depression1
  • Multiple Sclerosis1
  • Anxiety1
  • Lung Cancer1

Birmingham, Alabama1 trial

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

UAB, Psychiatry and Behavioral Neurology

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.